UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Combined RNAi-mediated suppression of Rictor and EGFR resulted in complete tumor regression in an orthotopic glioblastoma tumor model

PloS one, 2013-03, Vol.8 (3), p.e59597

2013

Volltextzugriff (PDF)

Vascular normalization in orthotopic glioblastoma following intravenous treatment with lipid-based nanoparticulate formulations of irinotecan (Irinophore C™), doxorubicin (Caelyx®) or vincristine

BMC cancer, 2011-04, Vol.11 (1), p.124-124, Article 124

2011

Volltextzugriff (PDF)

In Vitro and in Vivo Characterization of Doxorubicin and Vincristine Coencapsulated within Liposomes through Use of Transition Metal Ion Complexation and pH Gradient Loading

Clinical cancer research, 2004-01, Vol.10 (2), p.728-738

2004

Volltextzugriff (PDF)

Validating the use of a luciferase labeled breast cancer cell line, MDA435LCC6, as a means to monitor tumor progression and to assess the therapeutic activity of an established anticancer drug, docetaxel (Dt) alone or in combination with the ILK inhibitor, QLT0267

Cancer biology & therapy, 2011-05, Vol.11 (9), p.826-838

2011

Volltextzugriff (PDF)

Treatment of HER-2/neu Overexpressing Breast Cancer Xenograft Models with Trastuzumab (Herceptin) and Gefitinib (ZD1839): Drug Combination Effects on Tumor Growth, HER-2/neu and Epidermal Growth Factor Receptor Expression, and Viable Hypoxic Cell Fraction

Clinical cancer research, 2004-04, Vol.10 (7), p.2512-2524

2004

Volltextzugriff (PDF)

Surface-associated serum proteins inhibit the uptake of phosphatidylserine and poly(ethylene glycol) liposomes by mouse macrophages

Biochimica et biophysica acta, 2001-07, Vol.1513 (1), p.25-37

2001

Volltextzugriff (PDF)

The combination of gefitinib and RAD001 inhibits growth of HER2 overexpressing breast cancer cells and tumors irrespective of trastuzumab sensitivity

BMC cancer, 2011-10, Vol.11 (1), p.420-420, Article 420

2011

Volltextzugriff (PDF)

Silencing Bcl-2 in models of mantle cell lymphoma is associated with decreases in cyclin D1, nuclear factor-κB, p53, bax, and p27 levels

Molecular cancer therapeutics, 2008-04, Vol.7 (4), p.749-758

2008

Volltextzugriff (PDF)

Accumulation of liposomal lipid and encapsulated doxorubicin in murine Lewis lung carcinoma: the lack of beneficial effects by coating liposomes with poly(ethylene glycol)

The Journal of pharmacology and experimental therapeutics, 1997-03, Vol.280 (3), p.1319

1997

Volltextzugriff (PDF)

Role of drug release and liposome-mediated drug delivery in governing the therapeutic activity of liposomal mitoxantrone used to treat human A431 and LS180 solid tumors

The Journal of pharmacology and experimental therapeutics, 2000-01, Vol.292 (1), p.337

2000

Volltextzugriff (PDF)

Characterization of Long-Circulating Cationic Nanoparticle Formulations Consisting of a Two-Stage PEGylation Step for the Delivery of siRNA in a Breast Cancer Tumor Model

Journal of pharmaceutical sciences, 2013-01, Vol.102 (1), p.227-236

2013

Volltextzugriff (PDF)

Influence of drug release characteristics on the therapeutic activity of liposomal mitoxantrone

The Journal of pharmacology and experimental therapeutics, 1997-04, Vol.281 (1), p.566

1997

Volltextzugriff (PDF)

Development of a weak-base docetaxel derivative that can be loaded into lipid nanoparticles

Journal of controlled release, 2010-06, Vol.144 (3), p.332-340

2010

Volltextzugriff (PDF)

A Cationic Liposomal Vincristine Formulation with Improved Vincristine Retention, Extended Circulation Lifetime and Increased Anti-Tumor Activity

Letters in drug design & discovery, 2007-09, Vol.4 (6), p.426-433

2007

Volltextzugriff (PDF)

Kupffer Cells Do Not Play a Role in Governing the Efficacy of Liposomal Mitoxantrone Used to Treat a Tumor Model Designed to Assess Drug Delivery to Liver

Clinical cancer research, 2000-11, Vol.6 (11), p.4449-4460

2000

Volltextzugriff (PDF)

Irinophore C™, a lipid nanoparticle formulation of irinotecan, abrogates the gastrointestinal effects of irinotecan in a rat model of clinical toxicities

Investigational new drugs, 2014-12, Vol.32 (6), p.1071-1082

2014

Volltextzugriff (PDF)

Liposomal encapsulation of topotecan enhances anticancer efficacy in murine and human xenograft models

Cancer research (Chicago, Ill.), 2000-07, Vol.60 (13), p.3389-3393

2000

Volltextzugriff (PDF)

Polyethylene Glycol Modified Phospholipids Stabilize Emulsions Prepared from Triacylglycerol

Journal of pharmaceutical sciences, 1994-11, Vol.83 (11), p.1558-1564

1994

Volltextzugriff (PDF)

Transfer of liposomal drug carriers from the blood to the peritoneal cavity of normal and ascitic tumor-bearing mice

Cancer chemotherapy and pharmacology, 1994, Vol.34 (2), p.137-146

1994

Volltextzugriff (PDF)

Abstract 1684: Autophagy inhibition as an effective strategy for sensitizing triple-negative breast cancer cells to chemotherapy

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.1684-1684

2013

Volltextzugriff (PDF)

Vascular normalization in orthotopic glioblastoma following intravenous treatment with lipid-based nanoparticulate formulations of irinotecan or vincristine

BMC cancer, 2011-04, Vol.11, p.124

2011

Volltextzugriff (PDF)

Vascular normalization in orthotopic glioblastoma following intravenous treatment with lipid-based nanoparticulate formulations of irinotecan

BMC cancer, 2011-04, Vol.11, p.124

2011

Volltextzugriff (PDF)

Substantial increases in idarubicin plasma concentration by liposome encapsulation mediates improved antitumor activity

Journal of controlled release, 2005-06, Vol.105 (1), p.89-105

2005

Volltextzugriff (PDF)

Four human t(11;14)(q13;q32)-containing cell lines having classic and variant features of Mantle Cell Lymphoma

Leukemia research, 2006-04, Vol.30 (4), p.449-457

2006

Volltextzugriff (PDF)

Silencing Bcl-2 in models of mantle cell lymphoma is associated with decreases in cyclin D1, nuclear factor-kappaB, p53, bax, and p27 levels

Molecular cancer therapeutics, 2008-04, Vol.7 (4), p.749-758

2008

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(35)

Sprache

Englisch
(35)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Combined RNAi-mediated suppression of Rictor and EGFR resulted in complete tumor regression in an orthotopic glioblastoma tumor model

Vascular normalization in orthotopic glioblastoma following intravenous treatment with lipid-based nanoparticulate formulations of irinotecan (Irinophore C™), doxorubicin (Caelyx®) or vincristine

In Vitro and in Vivo Characterization of Doxorubicin and Vincristine Coencapsulated within Liposomes through Use of Transition Metal Ion Complexation and pH Gradient Loading

Validating the use of a luciferase labeled breast cancer cell line, MDA435LCC6, as a means to monitor tumor progression and to assess the therapeutic activity of an established anticancer drug, docetaxel (Dt) alone or in combination with the ILK inhibitor, QLT0267

Treatment of HER-2/neu Overexpressing Breast Cancer Xenograft Models with Trastuzumab (Herceptin) and Gefitinib (ZD1839): Drug Combination Effects on Tumor Growth, HER-2/neu and Epidermal Growth Factor Receptor Expression, and Viable Hypoxic Cell Fraction

Surface-associated serum proteins inhibit the uptake of phosphatidylserine and poly(ethylene glycol) liposomes by mouse macrophages

The combination of gefitinib and RAD001 inhibits growth of HER2 overexpressing breast cancer cells and tumors irrespective of trastuzumab sensitivity

Silencing Bcl-2 in models of mantle cell lymphoma is associated with decreases in cyclin D1, nuclear factor-κB, p53, bax, and p27 levels

Accumulation of liposomal lipid and encapsulated doxorubicin in murine Lewis lung carcinoma: the lack of beneficial effects by coating liposomes with poly(ethylene glycol)

Role of drug release and liposome-mediated drug delivery in governing the therapeutic activity of liposomal mitoxantrone used to treat human A431 and LS180 solid tumors

Characterization of Long-Circulating Cationic Nanoparticle Formulations Consisting of a Two-Stage PEGylation Step for the Delivery of siRNA in a Breast Cancer Tumor Model

Influence of drug release characteristics on the therapeutic activity of liposomal mitoxantrone

Development of a weak-base docetaxel derivative that can be loaded into lipid nanoparticles

A Cationic Liposomal Vincristine Formulation with Improved Vincristine Retention, Extended Circulation Lifetime and Increased Anti-Tumor Activity

Kupffer Cells Do Not Play a Role in Governing the Efficacy of Liposomal Mitoxantrone Used to Treat a Tumor Model Designed to Assess Drug Delivery to Liver

Irinophore C™, a lipid nanoparticle formulation of irinotecan, abrogates the gastrointestinal effects of irinotecan in a rat model of clinical toxicities

Liposomal encapsulation of topotecan enhances anticancer efficacy in murine and human xenograft models

Polyethylene Glycol Modified Phospholipids Stabilize Emulsions Prepared from Triacylglycerol

Transfer of liposomal drug carriers from the blood to the peritoneal cavity of normal and ascitic tumor-bearing mice

Abstract 1684: Autophagy inhibition as an effective strategy for sensitizing triple-negative breast cancer cells to chemotherapy

Vascular normalization in orthotopic glioblastoma following intravenous treatment with lipid-based nanoparticulate formulations of irinotecan or vincristine

Vascular normalization in orthotopic glioblastoma following intravenous treatment with lipid-based nanoparticulate formulations of irinotecan

Substantial increases in idarubicin plasma concentration by liposome encapsulation mediates improved antitumor activity

Four human t(11;14)(q13;q32)-containing cell lines having classic and variant features of Mantle Cell Lymphoma

Silencing Bcl-2 in models of mantle cell lymphoma is associated with decreases in cyclin D1, nuclear factor-kappaB, p53, bax, and p27 levels

Suchergebnisse filtern